RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Imu Biosciences

Imu Biosciences

Unlocking the potential of the immune system.

Latest funding

$53M Series A ·

Led by IQ Capital · Source: fundraisingfox.com

Total raised: $67.66M across 2 sourced rounds

All 2 rounds ↓
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Life Science, Precision Medicine.
Stage: Series A.
Based in: London, United Kingdom.
Founded: 2021.
Total raised: $67.66M in 2 sourced rounds.
Last round: Jun 1, 2026 · 167 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Sep 29, 2026.

Signals

Website registeredAug 5, 2022 (4 years old)
About Imu Biosciences

IMU's cutting-edge platform decodes complex immune challenges to drive breakthroughs and better health outcomes.

TIMELINE · MONEY RAISED

Imu Biosciences | 537 days from website to first raise on record

Raised $68M in 2 sourced rounds·1 signal before the first raise
$17M$34M$51M$68MSEPAPRNOVJUNJAN 2025AUGMAROCT$68M||WEBSITE CREATED · AUG 5, 2022$14.66M Series A · Jan 24, 2024$14.66M A · JAN '24$53M Series A · Jun 1, 2026$53M A · JUN '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series A$53MIIQ Capitalfundraisingfox.com
Series A$14.66MCCOREangelsmorningstar.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Imu Biosciences

Other companies backed by IQ Capital

IQ Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/imu-biosciences (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy